Novuson Surgical Inc.

Novuson has developed what we believe is the next generation of electrosurgical devices that are safer and more effective than current electrosurgical devices. We plan for our Direct Therapeutic Ultrasound surgical devices to disrupt the surgical device market, improving patient safety. Novuson is pre-revenue and in the prototype phase - - (Novuson has four prototype products (of which our 3mm Mini LS is close to regulatory clearance) and an energy console.)

StartEngine OWNERS Exclusive Click here to learn more

$499+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

Friends
Invest within the first 48 hours and receive 20% bonus shares.




1
days

13
hours

53
mins

28
secs

$5,000+ Investment
Tier 1
Invest $5,000+ and receive 5% bonus shares.

$10,000+ Investment
Tier 2
Invest $10,000+ and receive 10% bonus shares.

$25,000+ Investment
Tier 3
Invest $25,000+ and receive 25% bonus shares.

Safer Technology - Our patented DTU technology leaves no burned tissue, no charred tissue, and no carcinogenic smoke

Market Disruptor - Novuson’s technology solves the weaknesses of the two market-dominant electrosurgical solutions

Strategic Investments and Partnerships - Secured investment from major medical technology company and currently in negotiation for additional strategic partnerships

Carla Corkern



Director


Intellectually curious and passionate about people, process, and profit!

I love to manage processes, create cross-functional teams, create high energy & high performing teams.

I've succeeded in start-up environments, turn around scenarios and M&A integrations for both public and private companies by building plans, teams, campaigns, processes, from beginning to on-going concern. Pre-revenue to ~$50 Million in ARR.

Experience in many technology markets: Healthcare, Automation, SAAS Platforms for Supply Chain and Healthcare, Enterprise infrastructure & applications, EAI, corporate portals, knowledge management, content management, search technology, XML infrastructure technology, security/user management, wireless/mobile apps, networking, groupware, personal productivity applications















Sam Liao



Director


Previously with Lakeside, Metropolitan Investments and Merrill Lynch Capital Investments. Mr. Liao brings financial and investment oversight to Novuson’s Board















Marco Daoura



EVP of Product and Programs


Mr. Daoura graduated from the University of Washington with both a Bachelor of Science in Electrical Engineering and a Master of Science in BioEngineering with focus on Control Theory and Molecular Biotechnology. He has over 20 years in the healthcare industry from Philips Healthcare to Fujifilm Medical Systems, UltraLinq Healthcare. His work in innovation crosses many multidisciplinary areas from technology development, to technology architecture, program management, product services, product management and marketing, and market commercialization.















Derek Khorsand



Chief Medical Officer


Derek grew up in a small town in southwest Washington and is a graduate of the University of Washington School of Medicine, where he was the top graduate in his class. After a year of training in general surgery, Derek trained in Interventional Radiology at the University of Washington, where he was Chief Resident. He has a strong background in basic and clinical research and experience in medical device commercialization.















Jean Maixner



EVP Finance


Founder and Hospital Administrator Animal Critical Care and Emergency Services, 2 locations, 100+ employees, Exit via Acquisition